Cargando…

Pharmacovigilance on olanzapine

Detalles Bibliográficos
Autores principales:	Lingeswaran, Anand, Shetty, Harsha, Lahon, Kigshuk, Paramel, Amit, Sharma, Gyaneshwar
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941621/ https://www.ncbi.nlm.nih.gov/pubmed/20927256 http://dx.doi.org/10.4103/0253-7613.68438

Ejemplares similares

A retrospective study of extrapyramidal syndromes with second generation antipsychotics in the psychiatric unit of a tertiary care teaching hospital
por: Lahon, Kingshuk, et al.
Publicado: (2012)

Sexual dysfunction with the use of antidepressants in a tertiary care mental health setting – a retrospective case series
por: Lahon, Kingshuk, et al.
Publicado: (2011)

Suicide in Puducherry, India: A Public Health Burden
por: Lingeswaran, Anand
Publicado: (2012)

Aripiprazole for olanzapine-induced symptomatic hyper prolactinemia
por: Aggarwal, Ashish, et al.
Publicado: (2010)

Management Dilemma in Olanzapine Induced Restlessness and Cramps in Legs
por: Kar, Sujita Kumar, et al.
Publicado: (2017)

"Neck Dyskinesia With Olanzapine-a case report"
por: Sidana, Ajeet, et al.
Publicado: (2004)

Pharmacovigilance in vaccines
por: Budhiraja, Salil, et al.
Publicado: (2010)

Asymmetric, Tender Gynecomastia Induced by Olanzapine in a Young Male
por: Shahi, Mohit Kumar, et al.
Publicado: (2017)

Hyperglycemia associated with olanzapine treatment
por: Kumar, P. N. Suresh, et al.
Publicado: (2011)

Treatment of Delusional Infestation with Olanzapine
por: Kansal, Naveen Kumar, et al.
Publicado: (2012)

Caution with olanzapine use in dementia
Publicado: (2021)

Role of a medical advisor in pharmacovigilance as a business support service
por: Dang, Amit, et al.
Publicado: (2015)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

Olanzapine-induced reversible skin eruption
por: Deshmukh, Rohit P.
Publicado: (2023)

Breast enlargement associated with low dose olanzapine
por: Aggarwal, Ashish, et al.
Publicado: (2011)

Severe olanzapine-induced liver function test elevation
por: Crouse, Ericka, et al.
Publicado: (2023)

Diabetes Insipidus Induced by Oral Olanzapine at Therapeutic Dose
por: Kumar, Mohan Prem, et al.
Publicado: (2022)

The Facts and Fiction of Olanzapine-Samidorphan Fixed Dose Combination
por: Das, Nileswar, et al.
Publicado: (2022)

Postinjection delirium/sedation syndrome with long-acting olanzapine pamoate in a middle-aged female
por: Upadhyay, Apoorva, et al.
Publicado: (2017)

Pharmacovigilance in drugs used in the treatment of drug dependence
por: Thota, Anusha, et al.
Publicado: (2017)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011)

Black hairy tongue with olanzapine: A rare case report
por: Kanodia, Shubhra, et al.
Publicado: (2017)

Letter to editor regarding “comparison of efficacy of haloperidol and olanzapine in the treatment of delirium”
por: Kumar, Pawan, et al.
Publicado: (2019)

Dysmorphic Delusion and Olanzapine-Induced Postpartum Dermatosis in a Case of Schizophrenia
por: Sutar, Roshan, et al.
Publicado: (2019)

Olanzapine-induced acute generalized exanthematous pustulosis: A case report
por: Jakhar, Jitender, et al.
Publicado: (2021)

Olanzapine Induced Hyponatraemia
por: Dudeja, Sonia J, et al.
Publicado: (2010)

Olanzapine-Associated Chronic Urinary Retention and Ciliochoroidal Effusion: Rare Adverse Effects of a Commonly Prescribed Antipsychotic
por: Purohith, Abhiram Narasimhan, et al.
Publicado: (2022)

Good pharmacovigilance practice: Need of the hour from pharmaceutical companies
por: Bhati, Neha, et al.
Publicado: (2015)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic
por: La Gatta, A., et al.
Publicado: (2021)

The future role of pharmacists and pharmacovigilance after the advent of the COVID-19 pandemic
por: La Gatta, A., et al.
Publicado: (2021)

A Call to Enhance Active and Transparent Pharmacovigilance for COVID-19 Vaccines
por: Kunene, Khontile Nobuhle, et al.
Publicado: (2023)

Comment on “Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review”
por: Todtenkopf, Mark S., et al.
Publicado: (2023)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020)

Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring: Some Additional Information
por: Patel, C
Publicado: (2011)

Comment on: “Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance”
por: Giugliano, Robert P., et al.
Publicado: (2021)

Cluster headache after COVID-19 vaccination with Comirnaty: A signal in pharmacovigilance database()
por: Rochoy, Michaël, et al.
Publicado: (2022)

Angioedema in a patient with COVID-19 who received depot olanzapine pamoate: Diagnostic dilemma posed
por: Ranjan, Rajeev, et al.
Publicado: (2021)

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
por: Prokopez, Cintia R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6n197t52pruo47q34ggnekim5j